News
Centre Approves Nasal #vaccine to Be Used as a Heterologous Booster and Will Be Available ... - Latest Tweet by IANS India
The latest Tweet by IANS India states, 'Centre approves Nasal #vaccine to be used as a heterologous booster and will be available in private hospitals in initial phase: Source'
Centre approves Nasal #vaccine to be used as a heterologous booster and will be available in private hospitals in initial phase: Source— IANS (@ians_india) December 23, 2022
(The above story first appeared on LatestLY on Dec 23, 2022 11:40 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
